Coronavirus: vaccine hopes rise on promising Pfizer-BioNTech trial results

//Coronavirus: vaccine hopes rise on promising Pfizer-BioNTech trial results

Coronavirus: vaccine hopes rise on promising Pfizer-BioNTech trial results

Promising data on a potential coronavirus vaccine developed by American firm Pfizer and German partner BioNTech has raised hopes of an answer to the pandemic, but scientists caution that it is too early for confidence.Pfizer announced on Monday that clinical trials indicated that its vaccine candidate was more than 90 per cent effective in preventing symptomatic infection of Covid-19 – the disease caused by the coronavirus – compared with volunteers given a placebo.The announcement came as…

Article by [author-name] (c) South China Morning Post - Read full story here.

By | 2020-11-10T16:05:12+00:00 November 10th, 2020|Headlines|Comments Off on Coronavirus: vaccine hopes rise on promising Pfizer-BioNTech trial results